Increased Rheumatoid Factor production in patients with severe COVID-19.

Increased Rheumatoid Factor production in patients with severe COVID-19.

Publication date: Jul 01, 2024

Searching for Rheumatoid Factors (RF) in patients with coronavirus disease (COVID-19) has rarely been described. To investigate the association between RF isotypes (IgM, IgA, and IgG) and different clinical presentations of COVID-19 in a series of Tunisian patients. Eighty-two COVID-19 patients were enrolled in this study. Symptomatic cases were recruited from the Department of COVID-19 and the intensive care unit (ICU) of the University Hospital of Mahdia, Tunisia, from January 2021 to March 2021. Different RF isotypes were assessed using a commercial enzyme-linked immunosorbent assay (ELISA). Forty-one patients (50%) had RF of any isotype. Thirty-two patients (39%) were tested positive for RF-IgM. Symptomatic forms of the disease were associated with RF-IgM positivity (p = 0. 005). The mean concentration of RF-IgM was higher in the severe form than in the moderate and asymptomatic forms (p = 0. 006). Our study suggests that the production of RF-IgM isotype is increased in patients with severe COVID-19.

Concepts Keywords
Coronavirus Adult
Rarely Aged
Rheumatoid COVID-19
Thirty Covid-19
Tunisia Enzyme-Linked Immunosorbent Assay
Female
Humans
Immunoglobulin A
Immunoglobulin A
Immunoglobulin G
Immunoglobulin G
Immunoglobulin M
Immunoglobulin M
Infection
Male
Middle Aged
Rheumatoid Factor
Rheumatoid Factor
Rheumatoid factor
SARS-CoV-2
Tunisia
Viruses

Semantics

Type Source Name
disease IDO production
disease MESH COVID-19
pathway KEGG Coronavirus disease
disease IDO assay
disease MESH Infection

Original Article

(Visited 1 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *